Canvas & Ratio
Choose your destination platform format
Layout Template
Choose a content structure for your slides
Preset Themes
Typography & Sizing
Brand Kit Customization
AGENCYConfigure brand assets for headers & footers
Outro Slide CTA
Customize your closing call-to-action slide
Background Pattern
Build Your Carousel
Drag and drop any post card below onto a slide, or use the quick buttons to insert content/images instantly!
MEBENDAZOLE Patent for Treatment of CANCER Mebendazole is sometimes called an “animal dewormer” like Ivermectin and Fenbendazole. On Sep.7, 2021, Johns Hopkins University in Baltimore, MD secured a patent for MEBENDAZOLE for this use: 1. Repurposed for Glioblastoma Therapy (as an oral drug mebendazole polymorph C is a superior form, and it reaches the brain and brain tumors in effective concentrations) 2. Mebendazole may also be used for therapy of other cancers, as well as a chemo-preventative agent. Patent No. US 11,110,079 B2 Date of Patent: Sep.7, 2021 The title of the patent: “Mebendazole Polymorph for Treatment and Prevention of Tumors” Applicant: Johns Hopkins University Inventors: Gregory Riggins, et al I will let this sink in. This is what I have been working with for the past 2 years, in the largest Ivermectin Cancer Project in the world. 9000+ Cancer patients. You have never seen this patent in the news. You have never seen any Oncologist talk about this patent. Yet, this is a game changer for Glioblastoma Cancer patients.
